Need to Know: Seeking More and Better Testing-Healthy Returns
The U.S. response to the coronavirus pandemic has been hampered by a severe shortage of tests. To overcome this crisis and return to normalcy, more, better and new tests for COVID-19 antibodies will be necessary. How can the public and private sectors work together to achieve this goal, and how can the results be leveraged for a better understanding of how the virus works? CNBC's Chrissy Farr speaks with Jessica Mega, Co-Founder and Chief Medical and Scientific Officer, Verily, and Tom Polen, CEO, BD (Becton, Dickinson and Company) at CNBC's Healthy Returns Virtual Summit.